logo
Share SHARE
FONT-SIZE Plus   Neg

Maruti Suzuki India Launches Ertiga

India's largest car manufacturer Maruti Suzuki India Ltd. launched its utility vehicle 'Ertiga' in New Delhi on Thursday at an introductory price ranging between Rs.5.89 lakh and Rs.8.45 lakh (ex-showroom, Delhi.).

Ertiga will come in both petrol and diesel versions. With this car, the company has introduced its K-14 VVT 1.4 litre petrol engine in India. Maruti has termed it to be Life Utility Vehicle (LUV).

The petrol variant of Ertiga LXi is prices at Rs.5.89 lakh, while Ertiga Vxi and Ertiga Zxi is priced at Rs.6.60 lakh and Rs.7.30 lakh, respectively.

The diesel variation of Ertiga LDi is priced at Rs.7.30 lakh, whereas Ertiga VDi and Ertiga ZDi is tagged at Rs.7.90 lakh and Rs.8.45 lakh, respectively.

The petrol variant is powered with all new powerful K-Series, 1373cc VVT (K14B) engine, while diesel variant is powered by the highly acclaimed 1248cc DDiS VGT engine.

At the BSE, Maruti Suzuki India shares are currently trading at Rs.1,307.05, up 2.69 percent from the previous close.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

More Breaking News

0 Articles
Editors Pick
Capricor Therapeutics, Inc., a clinical-stage biotechnology company for cardiac and other medical conditions, announced Tuesday positive six-month results from the randomized phase I/II HOPE clinical trial in Duchenne muscular dystrophy or DMD. The HOPE clinical trial was designed to evaluate the safety and exploratory efficacy of CAP-1002. Frozen hash browns, made by McCain Foods USA, are being recalled from stores in nine states, citing that the potatoes may contain extraneous golf ball materials. The product is sold and distributed under the Roundy's and Harris Teeter retail brands. Swiss drug giant Novartis AG reported Tuesday a decline in its first-quarter net profit with weak sales mainly due to negative impact of generic competition and pricing. However, core earnings per share topped analysts' estimates. Further, the company backed its fiscal 2017 forecast. Novartis shares were gaining around 3 percent in the morning trading in Zurich.
comments powered by Disqus
Follow RTT